PROTHENA CORPORATION PUBLIC LIMITED COMPANY Income Taxes Paid
PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) reported Income Taxes Paid of $1.20 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-05.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2019-11-05
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY income taxes paid for the quarter ending 2019-09-30 was $445.00K, a 15.24% decline year-over-year.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY income taxes paid for the quarter ending 2019-06-30 was $701.00K, a 21.70% increase year-over-year.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY income taxes paid for the quarter ending 2019-03-31 was $54.00K.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY income taxes paid for the quarter ending 2018-12-31 was -$2.10M.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY income taxes paid for fiscal 2018 was -$995.00K, a 438.44% decline from fiscal 2017.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY income taxes paid for fiscal 2017 was $294.00K, a 48.87% decline from fiscal 2016.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY income taxes paid for fiscal 2016 was $575.00K, a 30.09% increase from fiscal 2015.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY income taxes paid for fiscal 2015 was $442.00K, a 72.17% decline from fiscal 2014.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 3 month as first filed | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|---|
| 2019-09-30 | $445.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $1.15M derived: sum of 2 quarters · filed 2019-11-05 | $1.20M 10-Q · filed 2019-11-05 | -$896.00K derived: sum of 4 quarters · filed 2019-11-05 | |
| 2019-06-30 | $701.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $755.00K 10-Q · filed 2019-08-06 | -$1.34M derived: sum of 3 quarters · filed 2019-08-06 | -$816.00K derived: sum of 4 quarters · filed 2019-11-05 | |
| 2019-03-31 | $54.00K 10-Q · filed 2019-05-07 | -$2.04M derived: sum of 2 quarters · filed 2019-05-07 | -$1.52M derived: sum of 3 quarters · filed 2019-11-05 | -$941.00K derived: sum of 4 quarters · filed 2019-11-05 | |
| 2018-12-31 | -$2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | -$1.57M derived: sum of 2 quarters · filed 2019-11-05 | -$995.00K derived: sum of 3 quarters · filed 2019-11-05 | -$995.00K 10-K · filed 2019-03-15 | |
| 2018-09-30 | $525.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $1.10M derived: sum of 2 quarters · filed 2019-11-05 | $1.10M 10-Q · filed 2019-11-05 | $1.10M derived: sum of 4 quarters · filed 2019-11-05 | |
| 2018-06-30 | $576.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $576.00K 10-Q · filed 2019-08-06 | $576.00K derived: sum of 3 quarters · filed 2019-08-06 | $179.00K derived: sum of 4 quarters · filed 2019-08-06 | |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-07 | $0.00 derived: sum of 2 quarters · filed 2019-05-07 | -$397.00K derived: sum of 3 quarters · filed 2019-05-07 | $294.00K derived: sum of 4 quarters · filed 2019-05-07 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | -$397.00K derived: sum of 2 quarters · filed 2019-03-15 | $294.00K derived: sum of 3 quarters · filed 2019-03-15 | $294.00K 10-K · filed 2019-03-15 | |
| 2017-09-30 | -$397.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $294.00K derived: sum of 2 quarters · filed 2018-11-06 | $294.00K 10-Q · filed 2018-11-06 | -$688.00K derived: sum of 4 quarters · filed 2019-03-15 | |
| 2017-06-30 | $691.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $691.00K 10-Q · filed 2018-08-07 | -$291.00K derived: sum of 3 quarters · filed 2019-03-15 | $389.00K derived: sum of 4 quarters · filed 2019-03-15 | |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-09 | -$982.00K derived: sum of 2 quarters · filed 2019-03-15 | -$302.00K derived: sum of 3 quarters · filed 2019-03-15 | $192.00K derived: sum of 4 quarters · filed 2019-03-15 | |
| 2016-12-31 | -$982.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | -$302.00K derived: sum of 2 quarters · filed 2019-03-15 | $192.00K derived: sum of 3 quarters · filed 2019-03-15 | $575.00K 10-K · filed 2019-03-15 | |
| 2016-09-30 | $680.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $1.17M derived: sum of 2 quarters · filed 2017-11-07 | $1.56M 10-Q · filed 2017-11-07 | $1.56M derived: sum of 4 quarters · filed 2018-02-26 | |
| 2016-06-30 | $494.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $877.00K 10-Q · filed 2017-08-09 | $877.00K derived: sum of 3 quarters · filed 2018-02-26 | $877.00K derived: sum of 4 quarters · filed 2018-02-26 | |
| 2016-03-31 | $383.00K 10-Q · filed 2017-05-09 | -$383.00K 10-Q · filed 2016-05-04 | $383.00K derived: sum of 2 quarters · filed 2018-02-26 | $383.00K derived: sum of 3 quarters · filed 2018-02-26 | $383.00K derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $0.00 derived: sum of 2 quarters · filed 2018-02-26 | $0.00 derived: sum of 3 quarters · filed 2018-02-26 | $442.00K 10-K · filed 2018-02-26 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $0.00 derived: sum of 2 quarters · filed 2016-11-02 | $442.00K 10-Q · filed 2016-11-02 | $1.04M derived: sum of 4 quarters · filed 2017-02-27 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | $442.00K 10-Q · filed 2016-08-02 | $1.04M derived: sum of 3 quarters · filed 2017-02-27 | $1.59M derived: sum of 4 quarters · filed 2017-02-27 | |
| 2015-03-31 | $442.00K 10-Q · filed 2016-05-04 | $1.04M derived: sum of 2 quarters · filed 2017-02-27 | $1.59M derived: sum of 3 quarters · filed 2017-02-27 | $1.59M derived: sum of 4 quarters · filed 2017-02-27 | |
| 2014-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $1.15M derived: sum of 2 quarters · filed 2017-02-27 | $1.15M derived: sum of 3 quarters · filed 2017-02-27 | $1.59M 10-K · filed 2017-02-27 | |
| 2014-09-30 | $552.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $552.00K derived: sum of 2 quarters · filed 2015-11-02 | $988.00K 10-Q · filed 2015-11-02 | $1.52M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $436.00K 10-Q · filed 2015-08-05 | $969.00K derived: sum of 3 quarters · filed 2016-02-25 | $969.00K derived: sum of 4 quarters · filed 2016-02-25 | |
| 2014-03-31 | $436.00K 10-Q · filed 2015-05-06 | $969.00K derived: sum of 2 quarters · filed 2016-02-25 | $969.00K derived: sum of 3 quarters · filed 2016-02-25 | $1.21M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2013-12-31 | $533.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $533.00K derived: sum of 2 quarters · filed 2016-02-25 | $773.00K derived: sum of 3 quarters · filed 2016-02-25 | $796.00K 10-K · filed 2016-02-25 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $240.00K derived: sum of 2 quarters · filed 2014-11-04 | $263.00K 10-Q · filed 2014-11-04 | $263.00K derived: sum of 4 quarters · filed 2015-03-13 | |
| 2013-06-30 | $240.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $263.00K 10-Q · filed 2014-08-05 | $263.00K derived: sum of 3 quarters · filed 2015-03-13 | ||
| 2013-03-31 | $23.00K 10-Q · filed 2014-05-05 | $23.00K derived: sum of 2 quarters · filed 2015-03-13 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $0.00 10-K · filed 2015-03-13 | |||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-12 | ||||
| 2011-12-31 | $0.00 10-K · filed 2014-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |